milrinone has been researched along with digitoxin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Leier, CV | 1 |
Farah, AE | 1 |
Adams, KF; Berk, M; Brozena, SC; Colucci, WS; Cowley, AJ; Grabicki, JM; Kubo, SA; LeJemtel, T; Littler, WA; Sonnenblick, EH | 1 |
1 trial(s) available for milrinone and digitoxin
Article | Year |
---|---|
Efficacy of phosphodiesterase inhibition with milrinone in combination with converting enzyme inhibitors in patients with heart failure. The Milrinone Multicenter Trials Investigators.
Topics: Angiotensin-Converting Enzyme Inhibitors; Digitalis; Double-Blind Method; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Plants, Medicinal; Plants, Toxic; Pyridones; Time Factors; United States | 1993 |
4 other study(ies) available for milrinone and digitoxin
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
General overview and update of positive inotropic therapy.
Topics: Amrinone; Blood Pressure; Cardiotonic Agents; Digitoxin; Dobutamine; Dopamine; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Isoproterenol; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Pyridones; Stroke Volume; Time Factors | 1986 |
Historical perspectives on inotropic agents.
Topics: Alkaloids; Aminopyridines; Amrinone; Animals; Cardiotonic Agents; Catecholamines; Cats; Digitalis; Digitalis Glycosides; Dogs; Europe; Glucagon; History, 18th Century; History, 19th Century; History, 20th Century; Humans; Milrinone; Plants, Medicinal; Plants, Toxic; Pyridones; Ranidae; United States | 1986 |